
A dose of risk management
Published: 24 March 2009 11:20 GMT
Oracle on Monday announced plans to acquire Relsys, which develops drug safety and risk management applications.
The acquisition, which is expected to close by June, is designed to bolster Oracle's Health Sciences Global Business Unit, formed last summer. Health sciences is one of a number of industry sectors into which Oracle is delving via a buying spree.
Relsys develops applications designed to aid drug, biotech, and medical-device companies in streamlining their operations, adhering to regulatory compliance and improving the safety of their products.
With the acquisition, Oracle aims to provide its customers with the ability to identify safety risks earlier in the development cycle, as well as improvements in tracking the performance of their products after they hit the market.
Financial terms of the deal were not disclosed.
Original article: Oracle to acquire Relsys from CNET News.com
As your role you develops you will progress in to managing new and existing accounts. Executive Specialising in location and risk management ...
Strong technical skills, with key strengths in practical application of the sciences. Working knowledge of medical device development processes. Our ...
Up to 70KpaA world leading IT Outsourcing organisation are recruiting for Technical Architects to lead small to medium scale, complex medium risk ...
Agenda Setters 2009
Welcome to the ninth annual Agenda Setters poll – silicon.com's list of the top 50 most influential individuals in the technology and IT industries, from techies and CIOs to entrepreneurs and business leaders. Find out more in our latest special report.
Stories from the web...
Copyright © 2008 CBS Interactive Limited. All rights reserved. Top of page
Bob Tarzey Why you must rein in your power users When they do damage, it can be catastrophic to your business
Jon Collins Is losing a mobile device really such a big deal? How to minimise the damage to your business